ESMO expert Rodrigo Dienstmann comments on the findings of the RANGE and CheckMate 214 trials, presented at the second Presidential symposium at the ESMO 2017 Congress in Madrid, Spain.
04-10-2017 | Genitourinary cancers | ESMO 2017 | Video
04-10-2017 | Genitourinary cancers | ESMO 2017 | Video
ESMO expert Rodrigo Dienstmann comments on the findings of the RANGE and CheckMate 214 trials, presented at the second Presidential symposium at the ESMO 2017 Congress in Madrid, Spain.